Key result
taVNS reduces food intake and enhances energy expenditure in metabolic disorders via brain-gut coordination.
Why the study?
The dynamic mechanisms by which transcutaneous auricular vagus nerve stimulation maintains metabolic homeostasis through the gut-brain axis remain elusive.
Does transcutaneous auricular vagus nerve stimulation (taVNS) improve glucose and lipid metabolic disorders?
Does transcutaneous auricular vagus nerve stimulation (taVNS) improve glucose and lipid metabolic disorders?
Transcutaneous auricular vagus nerve stimulation (taVNS) represents a promising non-pharmacological strategy for managing metabolic disorders like obesity and type 2 diabetes via the gut-brain axis.
Answers are grounded in this paper and cite their sources.
Vagal modulation may merit exploration in metabolic disorders; leaves open clinical efficacy of transcutaneous auricular approaches.
Dysregulation of glucose and lipid metabolism is a systemic disorder involving intricate interactions between the central nervous system, which governs stress and emotional regulation, and peripheral organs such as the gastrointestinal tract, liver, and pancreas. As a key component of the autonomic nervous system, the vagus nerve plays a pivotal role in regulating metabolic homeostasis through its widespread distribution and bidirectional communication along the gut-brain axis. Transcutaneous auricular vagus nerve stimulation (taVNS) has emerged as a promising non-pharmacological therapy for metabolic disorders, modulating autonomic function via brain-gut coordination to reduce food intake and enhance energy expenditure, thereby alleviating obesity, type 2 diabetes, and related conditions. However, the dynamic mechanisms by which taVNS maintains homeostatic balance through the gut-brain axis, as well as its novel targets, mediators, and pathways, remain elusive. Based on the concept of "brain-gut interaction for holistic regulation", this review explores the potential mechanisms of taVNS in ameliorating glucose and lipid metabolic disorders, offering new perspectives and strategies for clinical intervention.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) conducted a review in Glucose and lipid metabolic disorders. Transcutaneous auricular vagus nerve stimulation (taVNS) was evaluated. Transcutaneous auricular vagus nerve stimulation (taVNS) modulates autonomic function via brain-gut coordination to reduce food intake and enhance energy expenditure in metabolic disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: